In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Aviv Regev, executive vice president and head of Genentech Research & Early Development (gRED) NVIDIA’s push into the life sciences sector has been rewarded by a wide-ranging deal with Roche’s ...
Apr. 27, 2026 A mysterious “golden orb” found more than two miles deep in the Gulf of Alaska left scientists baffled for over two years, sparking wild speculation about its origins. After an intensive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results